| (+)-artemisinic acid | decreases expression | ISO | RGD:69121 | 6480464 | artemisic acid results in decreased expression of CEBPA mRNA; more ... | CTD | PMID:23063590 |
| (+)-artemisinic acid | multiple interactions | ISO | RGD:69121 | 6480464 | [[artemisic acid results in decreased expression of CEBPA mRNA] which results in decreased expression of HMGCR mRNA] which results in decreased chemical synthesis of Cholesterol | CTD | PMID:23063590 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:10325 | 6480464 | epigallocatechin gallate inhibits the reaction [Carbon Tetrachloride results in decreased expression of CEBPA protein] | CTD | PMID:20438794 |
| 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | multiple interactions | EXP | | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [FSHB protein affects the expression of CEBPA mRNA] | CTD | PMID:19414516 |
| 17alpha-ethynylestradiol | decreases activity | EXP | | 6480464 | Ethinyl Estradiol results in decreased activity of CEBPA protein | CTD | PMID:12507762 |
| 17beta-estradiol | affects expression | ISO | RGD:10325 | 6480464 | Estradiol affects the expression of CEBPA mRNA | CTD | PMID:15598610 |
| 17beta-estradiol | decreases expression | ISO | RGD:69121 | 6480464 | Estradiol results in decreased expression of CEBPA mRNA | CTD | PMID:20106945 |
| 17beta-hydroxy-5alpha-androstan-3-one | decreases expression | ISO | RGD:69121 | 6480464 | Dihydrotestosterone results in decreased expression of CEBPA protein | CTD | PMID:18801408 |
| 17beta-hydroxy-5alpha-androstan-3-one | decreases expression | ISO | RGD:10325 | 6480464 | Dihydrotestosterone results in decreased expression of CEBPA mRNA; more ... | CTD | PMID:12960001 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10325 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of CEBPA mRNA] | CTD | PMID:15667827 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:10325 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CEBPA mRNA | CTD | PMID:14708085 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10325 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CEBPA mRNA | CTD | PMID:15034205 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10325 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CEBPA gene] | CTD | PMID:21762485 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69121 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CEBPA mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CEBPA mRNA | CTD | PMID:18796159 PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CEBPA mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10325 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CEBPA mRNA | CTD | PMID:16054899 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:10325 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CEBPA mRNA | CTD | PMID:14708085 PMID:16615095 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10325 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CEBPA mRNA | CTD | PMID:17407152 PMID:16054899 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10325 | 6480464 | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA mRNA]; more ... | CTD | PMID:16054899 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10325 | 6480464 | SRC protein promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of CEBPA mRNA] | CTD | PMID:14708085 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10325 | 6480464 | PD 98059 inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CEBPA protein] | CTD | PMID:12758056 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10325 | 6480464 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CEBPA mRNA]; more ... | CTD | PMID:17407152 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10325 | 6480464 | CEBPA protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of SLC2A4 mRNA]; more ... | CTD | PMID:16615095 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69121 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CEBPA mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CEBPA mRNA | CTD | PMID:18796159 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased activity of [[CEBPA protein binds to CEBPB protein] which binds to PTGS2 promoter]; more ... | CTD | PMID:11133817 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10325 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CEBPA mRNA | CTD | PMID:16054899 PMID:17407152 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:10325 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CEBPA protein | CTD | PMID:12758056 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:10325 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CEBPA mRNA | CTD | PMID:16615095 PMID:14708085 |
| 2-acetamidofluorene | decreases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in decreased expression of CEBPA protein | CTD | PMID:21785164 |
| 2-acetamidofluorene | decreases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in decreased expression of CEBPA protein | CTD | PMID:20188851 PMID:21785164 |
| 2-amino-2-deoxy-D-galactopyranose | multiple interactions | ISO | RGD:10325 | 6480464 | [Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CEBPA protein; more ... | CTD | PMID:22107987 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:10325 | 6480464 | 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA]; more ... | CTD | PMID:22298784 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:69121 | 6480464 | [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA; more ... | CTD | PMID:23152186 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:10325 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA mRNA; more ... | CTD | PMID:16054899 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:10325 | 6480464 | [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA protein; more ... | CTD | PMID:11101056 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:10325 | 6480464 | Benzo(a)pyrene inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of CEBPA mRNA]; more ... | CTD | PMID:19141685 |
| 3-isobutyl-1-methyl-7H-xanthine | increases expression | ISO | RGD:10325 | 6480464 | 1-Methyl-3-isobutylxanthine results in increased expression of CEBPA mRNA | CTD | PMID:19141685 |
| 3H-1,2-dithiole-3-thione | increases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in increased expression of CEBPA mRNA | CTD | PMID:19162173 |
| 4-hydroxynon-2-enal | increases expression | ISO | RGD:10325 | 6480464 | 4-hydroxy-2-nonenal results in increased expression of CEBPA mRNA | CTD | PMID:19191707 |
| 4-hydroxyphenyl retinamide | decreases expression | ISO | RGD:10325 | 6480464 | Fenretinide results in decreased expression of CEBPA mRNA | CTD | PMID:16467112 |
| 5-aza-2'-deoxycytidine | decreases methylation | ISO | RGD:69121 | 6480464 | decitabine results in decreased methylation of CEBPA promoter | CTD | PMID:19194470 |
| 5-aza-2'-deoxycytidine | affects methylation | ISO | RGD:69121 | 6480464 | decitabine affects the methylation of CEBPA promoter | CTD | PMID:17510391 |
| 5-azacytidine | decreases methylation | ISO | RGD:69121 | 6480464 | Azacitidine results in decreased methylation of CEBPA promoter | CTD | PMID:19194470 |
| 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of CEBPA mRNA | CTD | PMID:22504374 |
| aflatoxin B1 | affects expression | ISO | RGD:69121 | 6480464 | Aflatoxin B1 affects the expression of CEBPA protein | CTD | PMID:20106945 |
| aldehydo-D-glucosamine 6-phosphate | decreases expression | ISO | RGD:10325 | 6480464 | glucosamine 6-phosphate results in decreased expression of CEBPA protein | CTD | PMID:19427183 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:69121 | 6480464 | PTK2 protein inhibits the reaction [Tretinoin promotes the reaction [CEBPA protein binds to RB1 protein]]; more ... | CTD | PMID:16226872 |
| all-trans-retinoic acid | increases activity | ISO | RGD:69121 | 6480464 | Tretinoin results in increased activity of CEBPA protein | CTD | PMID:16226872 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:10325 | 6480464 | Tretinoin inhibits the reaction [CEBPA protein binds to RETN promoter] | CTD | PMID:15047602 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:69121 | 6480464 | Tretinoin promotes the reaction [CEBPA protein binds to MIR223 promoter]; more ... | CTD | PMID:16325577 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:69121 | 6480464 | Tretinoin inhibits the reaction [CEBPA protein binds to ALB promoter] | CTD | PMID:16608438 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CEBPA mRNA | CTD | PMID:16483693 |
| Aroclor 1254 | increases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of CEBPA mRNA | CTD | PMID:11163329 |
| arsenic atom | multiple interactions | ISO | RGD:69121 | 6480464 | Arsenic inhibits the reaction [CEBPA protein binds to PPARG protein] | CTD | PMID:23108036 |
| arsenic atom | decreases expression | ISO | RGD:69121 | 6480464 | Arsenic results in decreased expression of CEBPA mRNA; more ... | CTD | PMID:23108036 |
| arsenite(3-) | increases expression | ISO | RGD:10325 | 6480464 | arsenite results in increased expression of CEBPA mRNA | CTD | PMID:15868481 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10325 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of CEBPA mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | ISO | RGD:10325 | 6480464 | Benzo(a)pyrene results in increased expression of CEBPA mRNA | CTD | PMID:15034205 |
| benzo[a]pyrene | increases expression | ISO | RGD:10325 | 6480464 | Benzo(a)pyrene results in increased expression of CEBPA protein | CTD | PMID:22249251 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10325 | 6480464 | Benzo(a)pyrene promotes the reaction [CEBPA protein binds to TRP63 promoter]; more ... | CTD | PMID:22249251 |
| benzo[a]pyrene | increases stability | ISO | RGD:10325 | 6480464 | Benzo(a)pyrene results in increased stability of CEBPA protein | CTD | PMID:22249251 |
| benzo[a]pyrene | increases expression | ISO | RGD:69121 | 6480464 | Benzo(a)pyrene results in increased expression of CEBPA mRNA | CTD | PMID:21714911 |
| benzo[a]pyrene | decreases expression | ISO | RGD:10325 | 6480464 | Benzo(a)pyrene results in decreased expression of CEBPA mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | ISO | RGD:69121 | 6480464 | Benzo(a)pyrene results in decreased expression of CEBPA mRNA | CTD | PMID:20106945 PMID:22316170 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10325 | 6480464 | Benzo(a)pyrene inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of CEBPA mRNA] | CTD | PMID:19141685 |
| benzo[a]pyrene | decreases expression | ISO | RGD:69121 | 6480464 | Benzo(a)pyrene results in decreased expression of CEBPA mRNA | CTD | PMID:20106945 |
| berberine | multiple interactions | ISO | RGD:10325 | 6480464 | Berberine inhibits the reaction [Clozapine results in increased expression of CEBPA protein]; more ... | CTD | PMID:20564506 |
| beta-carotene | decreases expression | ISO | RGD:10325 | 6480464 | beta Carotene results in decreased expression of CEBPA mRNA | CTD | PMID:21569430 |
| bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:10325 | 6480464 | Diethylhexyl Phthalate results in decreased expression of CEBPA mRNA | CTD | PMID:19245819 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CEBPA mRNA | CTD | PMID:20019905 |
| C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of CEBPA mRNA | CTD | PMID:19167457 |
| cadmium atom | decreases expression | EXP | | 6480464 | Cadmium results in decreased expression of CEBPA mRNA | CTD | PMID:17327700 |
| cadmium atom | decreases expression | ISO | RGD:10325 | 6480464 | Cadmium results in decreased expression of CEBPA protein | CTD | PMID:21848503 |
| cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of CEBPA mRNA | CTD | PMID:17327700 |
| cadmium dichloride | increases expression | ISO | RGD:69121 | 6480464 | Cadmium Chloride results in increased expression of CEBPA mRNA | CTD | PMID:12160620 |
| calcitriol | decreases expression | ISO | RGD:10325 | 6480464 | Calcitriol results in decreased expression of CEBPA mRNA | CTD | PMID:16368784 |
| calcium dichloride | increases activity | ISO | RGD:69121 | 6480464 | Calcium Chloride results in increased activity of CEBPA protein | CTD | PMID:17214633 |
| capsaicin | multiple interactions | EXP | | 6480464 | Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of CEBPA mRNA] | CTD | PMID:20359164 |
| capsaicin | decreases expression | ISO | RGD:10325 | 6480464 | Capsaicin results in decreased expression of CEBPA protein | CTD | PMID:17295509 |
| celecoxib | multiple interactions | EXP | | 6480464 | celecoxib inhibits the reaction [Dietary Fats results in decreased expression of CEBPA mRNA] | CTD | PMID:19247274 |
| cerulenin | decreases expression | ISO | RGD:10325 | 6480464 | Cerulenin results in decreased expression of CEBPA mRNA | CTD | PMID:15707987 |
| cholesterol | multiple interactions | ISO | RGD:69121 | 6480464 | [[artemisic acid results in decreased expression of CEBPA mRNA] which results in decreased expression of HMGCR mRNA] which results in decreased chemical synthesis of Cholesterol | CTD | PMID:23063590 |
| choline | multiple interactions | ISO | RGD:10325 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CEBPA gene | CTD | PMID:20938992 |
| clozapine | multiple interactions | ISO | RGD:10325 | 6480464 | Berberine inhibits the reaction [Clozapine results in increased expression of CEBPA protein]; more ... | CTD | PMID:20564506 |
| clozapine | increases expression | ISO | RGD:10325 | 6480464 | Clozapine results in increased expression of CEBPA mRNA; more ... | CTD | PMID:20564506 |
| cobalt dichloride | decreases expression | ISO | RGD:10325 | 6480464 | cobaltous chloride results in decreased expression of CEBPA mRNA | CTD | PMID:20594416 |
| copper(2+) sulfate | decreases expression | ISO | RGD:69121 | 6480464 | Copper Sulfate results in decreased expression of CEBPA mRNA | CTD | PMID:19549813 |
| curcumin | multiple interactions | ISO | RGD:10325 | 6480464 | Curcumin inhibits the reaction [Dietary Fats results in increased expression of CEBPA mRNA] | CTD | PMID:19297423 |
| cyclosporin A | decreases expression | ISO | RGD:69121 | 6480464 | Cyclosporine results in decreased expression of CEBPA mRNA | CTD | PMID:20106945 |
| DDT | multiple interactions | ISO | RGD:10325 | 6480464 | DDT results in increased activity of and results in increased localization of CEBPA protein | CTD | PMID:11911853 |
| dexamethasone | multiple interactions | ISO | RGD:10325 | 6480464 | 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA]; more ... | CTD | PMID:22298784 |
| dexamethasone | multiple interactions | ISO | RGD:69121 | 6480464 | [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA; more ... | CTD | PMID:23152186 |
| dexamethasone | increases expression | ISO | RGD:10325 | 6480464 | Dexamethasone results in increased expression of CEBPA mRNA | CTD | PMID:22956630 |
| dexamethasone | multiple interactions | ISO | RGD:10325 | 6480464 | butylparaben promotes the reaction [Dexamethasone results in increased expression of CEBPA mRNA] | CTD | PMID:22956630 |
| dexamethasone | multiple interactions | ISO | RGD:10325 | 6480464 | [INS1 protein co-treated with Dexamethasone] results in increased expression of CEBPA mRNA; more ... | CTD | PMID:11812925 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of CEBPA mRNA | CTD | PMID:15965953 PMID:12837037 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of CEBPA protein | CTD | PMID:15965953 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of CEBPA mRNA | CTD | PMID:12837037 PMID:15965953 |
| dexamethasone | multiple interactions | ISO | RGD:10325 | 6480464 | [Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA mRNA | CTD | PMID:9543393 |
| dexamethasone | multiple interactions | ISO | RGD:10325 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA mRNA; more ... | CTD | PMID:16054899 |
| dexamethasone | multiple interactions | ISO | RGD:10325 | 6480464 | [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA protein; more ... | CTD | PMID:11101056 |
| diarsenic trioxide | increases expression | ISO | RGD:69121 | 6480464 | arsenic trioxide results in increased expression of CEBPA mRNA | CTD | PMID:20458559 |
| diarsenic trioxide | decreases expression | ISO | RGD:69121 | 6480464 | arsenic trioxide results in decreased expression of CEBPA protein | CTD | PMID:19662097 |
| diarsenic trioxide | decreases expression | ISO | RGD:10325 | 6480464 | arsenic trioxide results in decreased expression of CEBPA protein | CTD | PMID:15916724 |
| dibutyl phthalate | decreases expression | ISO | RGD:10325 | 6480464 | Dibutyl Phthalate results in decreased expression of CEBPA mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:10325 | 6480464 | Dibutyl Phthalate results in decreased expression of CEBPA mRNA | CTD | PMID:17361019 PMID:21266533 |
| dicoumarol | multiple interactions | ISO | RGD:10325 | 6480464 | Dicumarol inhibits the reaction [CEBPA protein binds to TRP63 promoter] | CTD | PMID:22249251 |
| dicoumarol | multiple interactions | ISO | RGD:69121 | 6480464 | Dicumarol inhibits the reaction [NQO1 protein binds to CEBPA protein] | CTD | PMID:23086932 |
| diethylstilbestrol | increases expression | ISO | RGD:10325 | 6480464 | Diethylstilbestrol results in increased expression of CEBPA mRNA; more ... | CTD | PMID:22710028 |
| diethylstilbestrol | multiple interactions | ISO | RGD:10325 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [Diethylstilbestrol results in increased expression of CEBPA protein] | CTD | PMID:22710028 |
| dioxygen | decreases expression | ISO | RGD:10325 | 6480464 | Oxygen deficiency results in decreased expression of CEBPA mRNA | CTD | PMID:20594416 |
| doxorubicin | decreases expression | ISO | RGD:69121 | 6480464 | Doxorubicin results in decreased expression of CEBPA protein | CTD | PMID:19662097 |
| ethanol | decreases activity | ISO | RGD:10325 | 6480464 | Ethanol results in decreased activity of CEBPA protein | CTD | PMID:16737972 |
| ethanol | decreases expression | ISO | RGD:10325 | 6480464 | Ethanol results in decreased expression of CEBPA protein | CTD | PMID:16737972 |
| ethanol | multiple interactions | ISO | RGD:10325 | 6480464 | Vitamin E inhibits the reaction [Ethanol results in decreased activity of CEBPA protein]; more ... | CTD | PMID:16737972 |
| ethanol | decreases expression | ISO | RGD:69121 | 6480464 | Ethanol results in decreased expression of CEBPA protein | CTD | PMID:16737972 |
| etoposide | increases degradation | ISO | RGD:69121 | 6480464 | Etoposide results in increased degradation of CEBPA protein | CTD | PMID:19662097 |
| etoposide | decreases expression | ISO | RGD:69121 | 6480464 | Etoposide results in decreased expression of CEBPA mRNA; more ... | CTD | PMID:19662097 |
| folic acid | multiple interactions | ISO | RGD:10325 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CEBPA gene | CTD | PMID:20938992 |
| genistein | decreases expression | ISO | RGD:10325 | 6480464 | Genistein results in decreased expression of CEBPA mRNA | CTD | PMID:21048042 |
| glycerol 2-phosphate | multiple interactions | ISO | RGD:10325 | 6480464 | [Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of CEBPA protein | CTD | PMID:14505802 |
| herbimycin | multiple interactions | EXP | | 6480464 | herbimycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [[CEBPA protein binds to CEBPB protein] which binds to PTGS2 promoter]] | CTD | PMID:11133817 |
| hydroxytyrosol | decreases expression | ISO | RGD:10325 | 6480464 | 3,4-dihydroxyphenylethanol results in decreased expression of CEBPA mRNA | CTD | PMID:21569430 |
| indomethacin | multiple interactions | ISO | RGD:10325 | 6480464 | Indomethacin promotes the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CEBPA protein] | CTD | PMID:22107987 |
| L-ascorbic acid | multiple interactions | ISO | RGD:10325 | 6480464 | [Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of CEBPA protein | CTD | PMID:14505802 |
| L-methionine | multiple interactions | ISO | RGD:10325 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CEBPA gene | CTD | PMID:20938992 |
| lead diacetate | increases expression | ISO | RGD:10325 | 6480464 | lead acetate results in increased expression of CEBPA mRNA | CTD | PMID:20542052 |
| lead diacetate | decreases expression | ISO | RGD:10325 | 6480464 | lead acetate results in decreased expression of CEBPA mRNA | CTD | PMID:21829687 |
| lead(0) | increases expression | ISO | RGD:10325 | 6480464 | Lead results in increased expression of CEBPA | CTD | PMID:23086611 |
| menadione | affects expression | ISO | RGD:69121 | 6480464 | Vitamin K 3 affects the expression of CEBPA mRNA | CTD | PMID:20044591 |
| metformin | decreases expression | EXP | | 6480464 | Metformin results in decreased expression of CEBPA mRNA | CTD | PMID:19022234 |
| methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of CEBPA mRNA | CTD | PMID:22504374 |
| mifepristone | multiple interactions | ISO | RGD:10325 | 6480464 | Mifepristone inhibits the reaction [butylparaben results in increased expression of CEBPA mRNA] | CTD | PMID:22956630 |
| mono(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:10325 | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of CEBPA protein | CTD | PMID:21832167 |
| mono(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of CEBPA protein | CTD | PMID:21832167 |
| mono(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | Forskolin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of CEBPA protein] | CTD | PMID:21832167 |
| N-nitrosodiethylamine | decreases expression | ISO | RGD:69121 | 6480464 | Diethylnitrosamine results in decreased expression of CEBPA mRNA | CTD | PMID:21527772 |
| N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of CEBPA mRNA | CTD | PMID:19638242 |
| NAD zwitterion | multiple interactions | ISO | RGD:69121 | 6480464 | [NAD co-treated with NQO1 protein] results in decreased degradation of CEBPA protein | CTD | PMID:23086932 |
| NAD(+) | multiple interactions | ISO | RGD:69121 | 6480464 | [NAD co-treated with NQO1 protein] results in decreased degradation of CEBPA protein | CTD | PMID:23086932 |
| nevirapine | increases expression | ISO | RGD:69121 | 6480464 | Nevirapine results in increased expression of CEBPA mRNA | CTD | PMID:21619898 |
| nicotinic acid | increases expression | ISO | RGD:69121 | 6480464 | Niacin results in increased expression of CEBPA mRNA | CTD | PMID:19131065 |
| nimesulide | multiple interactions | ISO | RGD:10325 | 6480464 | nimesulide promotes the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CEBPA protein] | CTD | PMID:22107987 |
| nimesulide | multiple interactions | EXP | | 6480464 | nimesulide inhibits the reaction [Dietary Fats results in decreased expression of CEBPA mRNA] | CTD | PMID:19247274 |
| ochratoxin A | decreases expression | ISO | RGD:69121 | 6480464 | ochratoxin A results in decreased expression of CEBPA | CTD | PMID:20590410 |
| phenylephrine | decreases expression | EXP | | 6480464 | Phenylephrine results in decreased expression of CEBPA mRNA | CTD | PMID:19443575 |
| pirinixic acid | multiple interactions | ISO | RGD:10325 | 6480464 | [pirinixic acid co-treated with PPARA] results in decreased expression of CEBPA mRNA | CTD | PMID:20813756 |
| pirinixic acid | decreases expression | ISO | RGD:10325 | 6480464 | pirinixic acid results in decreased expression of CEBPA mRNA | CTD | PMID:18445702 PMID:20813756 |
| pirinixic acid | decreases expression | ISO | RGD:10325 | 6480464 | pirinixic acid results in decreased expression of CEBPA mRNA | CTD | PMID:20813756 PMID:18445702 |
| pirinixic acid | multiple interactions | ISO | RGD:69121 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CEBPA mRNA | CTD | PMID:19710929 |
| propiconazole | decreases expression | ISO | RGD:10325 | 6480464 | propiconazole results in decreased expression of CEBPA mRNA | CTD | PMID:21278054 |
| propylparaben | increases expression | ISO | RGD:10325 | 6480464 | propylparaben results in increased expression of CEBPA mRNA | CTD | PMID:22956630 |
| quercetin | decreases expression | ISO | RGD:69121 | 6480464 | Quercetin results in decreased expression of CEBPA mRNA | CTD | PMID:21632981 |
| raloxifene | decreases expression | ISO | RGD:69121 | 6480464 | Raloxifene results in decreased expression of CEBPA mRNA | CTD | PMID:15849065 |
| resveratrol | decreases expression | ISO | RGD:10325 | 6480464 | resveratrol metabolite results in decreased expression of CEBPA mRNA | CTD | PMID:22945685 |
| resveratrol | decreases expression | ISO | RGD:10325 | 6480464 | resveratrol results in decreased expression of CEBPA protein | CTD | PMID:22935344 |
| risperidone | multiple interactions | ISO | RGD:10325 | 6480464 | Berberine inhibits the reaction [Risperidone results in increased expression of CEBPA mRNA]; more ... | CTD | PMID:20564506 |
| risperidone | increases expression | ISO | RGD:10325 | 6480464 | Risperidone results in increased expression of CEBPA mRNA; more ... | CTD | PMID:20564506 |
| rosiglitazone | multiple interactions | ISO | RGD:10325 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA mRNA; more ... | CTD | PMID:16054899 |
| rosiglitazone | increases expression | ISO | RGD:10325 | 6480464 | rosiglitazone results in increased expression of CEBPA mRNA | CTD | PMID:12021203 PMID:18534569 |
| rosiglitazone | increases expression | ISO | RGD:10325 | 6480464 | rosiglitazone results in increased expression of CEBPA mRNA | CTD | PMID:12021203 |
| rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of CEBPA mRNA; more ... | CTD | PMID:19693701 |
| sildenafil | increases expression | ISO | RGD:10325 | 6480464 | sildenafil results in increased expression of CEBPA mRNA; more ... | CTD | PMID:20471953 |
| sirolimus | decreases expression | ISO | RGD:10325 | 6480464 | Sirolimus results in decreased expression of CEBPA mRNA | CTD | PMID:15358118 |
| stavudine | decreases expression | ISO | RGD:10325 | 6480464 | Stavudine results in decreased expression of CEBPA protein | CTD | PMID:15722030 |
| testosterone | decreases expression | ISO | RGD:10325 | 6480464 | Testosterone results in decreased expression of CEBPA mRNA; more ... | CTD | PMID:12960001 |
| tetrachloromethane | decreases expression | ISO | RGD:10325 | 6480464 | Carbon Tetrachloride results in decreased expression of CEBPA mRNA | CTD | PMID:17484886 |
| tetrachloromethane | multiple interactions | ISO | RGD:10325 | 6480464 | epigallocatechin gallate inhibits the reaction [Carbon Tetrachloride results in decreased expression of CEBPA protein] | CTD | PMID:20438794 |
| tetrachloromethane | decreases expression | ISO | RGD:10325 | 6480464 | Carbon Tetrachloride results in decreased expression of CEBPA protein | CTD | PMID:20438794 |
| thapsigargin | multiple interactions | ISO | RGD:10325 | 6480464 | Thapsigargin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of CEBPA mRNA] | CTD | PMID:19141685 |
| topiramate | decreases expression | EXP | | 6480464 | topiramate results in decreased expression of CEBPA mRNA | CTD | PMID:16979414 |
| trans-resveratrol | decreases expression | ISO | RGD:10325 | 6480464 | resveratrol metabolite results in decreased expression of CEBPA mRNA | CTD | PMID:22945685 |
| trans-resveratrol | decreases expression | ISO | RGD:10325 | 6480464 | resveratrol results in decreased expression of CEBPA protein | CTD | PMID:22935344 |
| triclosan | decreases expression | ISO | RGD:10325 | 6480464 | Triclosan results in decreased expression of CEBPA mRNA | CTD | PMID:15707987 |
| troglitazone | increases expression | ISO | RGD:69121 | 6480464 | troglitazone results in increased expression of CEBPA mRNA | CTD | PMID:19022234 |
| troglitazone | increases expression | ISO | RGD:10325 | 6480464 | troglitazone results in increased expression of CEBPA mRNA | CTD | PMID:12732648 more ... |
| troglitazone | increases expression | ISO | RGD:10325 | 6480464 | troglitazone results in increased expression of CEBPA mRNA | CTD | PMID:19682441 more ... |
| troglitazone | increases expression | ISO | RGD:10325 | 6480464 | troglitazone results in increased expression of CEBPA mRNA | CTD | PMID:8895337 more ... |
| troglitazone | increases expression | ISO | RGD:10325 | 6480464 | troglitazone results in increased expression of CEBPA mRNA | CTD | PMID:19682441 more ... |
| troglitazone | multiple interactions | ISO | RGD:69121 | 6480464 | troglitazone inhibits the reaction [TNF protein inhibits the reaction [INS protein results in increased expression of CEBPA mRNA]] | CTD | PMID:7956951 |
| troglitazone | increases expression | ISO | RGD:10325 | 6480464 | troglitazone results in increased expression of CEBPA mRNA | CTD | PMID:12732648 PMID:19682441 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of CEBPA mRNA | CTD | PMID:19022234 |
| troglitazone | increases expression | ISO | RGD:10325 | 6480464 | troglitazone results in increased expression of CEBPA mRNA | CTD | PMID:19682441 |
| tunicamycin | multiple interactions | ISO | RGD:10325 | 6480464 | Tunicamycin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of CEBPA mRNA] | CTD | PMID:19141685 |
| valproic acid | increases expression | ISO | RGD:69121 | 6480464 | Valproic Acid results in increased expression of CEBPA mRNA | CTD | PMID:19101580 |
| zidovudine | decreases expression | ISO | RGD:10325 | 6480464 | Zidovudine results in decreased expression of CEBPA protein | CTD | PMID:15722030 |
| zinc atom | multiple interactions | ISO | RGD:69121 | 6480464 | CEBPA protein promotes the reaction [MTF1 protein promotes the reaction [Zinc results in increased expression of MT2A mRNA]] | CTD | PMID:17363595 |
| zinc atom | increases response to substance | ISO | RGD:69121 | 6480464 | CEBPA protein results in increased susceptibility to Zinc | CTD | PMID:15389791 |
| zinc atom | multiple interactions | ISO | RGD:69121 | 6480464 | CEBPA protein inhibits the reaction [Zinc results in increased expression of MT2A mRNA] | CTD | PMID:15389791 |
| zinc(0) | multiple interactions | ISO | RGD:69121 | 6480464 | CEBPA protein promotes the reaction [MTF1 protein promotes the reaction [Zinc results in increased expression of MT2A mRNA]] | CTD | PMID:17363595 |
| zinc(0) | increases response to substance | ISO | RGD:69121 | 6480464 | CEBPA protein results in increased susceptibility to Zinc | CTD | PMID:15389791 |
| zinc(0) | multiple interactions | ISO | RGD:69121 | 6480464 | CEBPA protein inhibits the reaction [Zinc results in increased expression of MT2A mRNA] | CTD | PMID:15389791 |
| zoledronic acid | increases expression | ISO | RGD:69121 | 6480464 | zoledronic acid results in increased expression of CEBPA mRNA | CTD | PMID:20977926 |